ESC Professional Premium Access

The design and baseline data of the Quantitative flow ratio-guided revascularization strategy for patients undergoing primary valve surgery with concomitant coronary artery disease (QVAS) trial

Congress Presentation

About the speaker

Associate Professor Yunpeng Zhu

Rui Jin Hospital- Shanghai Jiaotong University School of Medicine, Shanghai (China)
1 presentation
0 follower

8 more presentations in this session

Effects of nicorandil, isosorbide mononitrate or diltiazem on radial artery grafts after coronary artery bypass grafting: the randomized ASRAB-pilot trial

Speaker: Associate Professor Y. Zhu (Shanghai, CN)

Thumbnail

Coronary bypass surgery guided by multislice computed tomography angiography in a low surgical risk population

Speaker: Professor P. Serruys (Galway, IE) Doctor Y. Onuma (Galway, IE)

Thumbnail

Histopathology and prognosis of new-onset atrio-ventricular block after coronary artery bypass graft surgery

Speaker: Miss A. Toiviainen (Turku, FI)

Thumbnail

Prevalence and prognostic value of thrombocytopenia in aortic valve replacement surgery: bioprosthesis versus mechanical prosthesis.

Speaker: Doctor L. Seoane (Buenos Aires, AR)

Thumbnail

Association of R2-CHA2DS2-VASc score and clinical outcomes after bioprosthetic valve replacement: Subanalysis from BPV-AF registry

Speaker: Doctor M. Sano (Kobe, JP)

Thumbnail

Access the full session

Optimising clinical outcomes after cardiac surgery

Speakers: Associate Professor Y. Zhu, Associate Professor Y. Zhu, Professor P. Serruys, Doctor Y. Onuma, Miss A. Toiviainen...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations